Interim-Treatment Quantitative PET Parameters Predict Progression and Death Among Patients With Hodgkin's Disease

Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-7-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

A Gene Expression-Based Score to Predict Interim Pet Positivity in Hodgkin Lymphoma Patients Treated With Abvd

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cost of Disease Progression in Patients With Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Interactions of Immunological Parameters Among Patients With Periodontal Disease

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Pretreatment Depressive Symptoms and Treatment Modality Predict Post-Treatment Disease-Specific Quality of Life Among Patients With Localized Prostate Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2012English

Hodgkin's Disease: Biology, Treatment, Prognosis

Blood
BiochemistryImmunologyCell BiologyHematology
1981English

Plasma Metabolomic Profiles Predict Near-Term Death Among Individuals With Lower Extremity Peripheral Arterial Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Correlation of Early Lymphocyte Recovery and Progression-Free Survival After Autologous Stem-Cell Transplant in Patients With Hodgkin's and Non-Hodgkin's Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy